Agnieszka Olejarz‐Maciej

Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands

Dorota Łażewska, Małgorzata Więcek, Joanna Ner et al. · European Journal of Medicinal Chemistry · 2014 · 51 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +5

Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay

Jürgen A. Bohnert, Sabine Schuster, Winfried V. Kern et al. · Antimicrobial Agents and Chemotherapy · 2016 · 47 citations · Full text

Escherichia Coli, Antimicrobial Chemotherapy, Drug Resistance +23

In the search for a lead structure among series of potent and selective hydantoin 5‐<scp>HT</scp>₇R agents: The drug‐likeness in vitro study

Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek et al. · Chemical Biology & Drug Design · 2017 · 47 citations · Full text

Antinociceptive effects of novel histamine H₃ and H₄ receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse

Katarzyna Popiołek-Barczyk, Dorota Łażewska, Gniewomir Latacz et al. · British Journal of Pharmacology · 2018 · 42 citations · Full text

Selenazolinium Salts as “Small Molecule Catalysts” with High Potency against ESKAPE Bacterial Pathogens

Karolina Witek, Muhammad Jawad Nasim, Markus Bischoff et al. · Molecules · 2017 · 41 citations · Full text